Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/20/21 → 11/20/23 |
Funding
- Atara Biotherapeutics Incorporated: $17,844.00
ATA188-MS-101: An Open-Label Phase 1 Study to Evaluate the Safety of ATA188 in Subjects with Progressive and Relapsing-Remitting Multiple Sclerosis
- Avasarala, Jagannadha (PI)
- Chalkley, Joshua (CoI)